{
    "Trade/Device Name(s)": [
        "MDx-Chex for BC-GP",
        "MDx-ChexTM for BC-GP",
        "MDx-Chex\u2122 for BC-GP"
    ],
    "Submitter Information": "Streck",
    "510(k) Number": "K231221",
    "Predicate Device Reference 510(k) Number(s)": [
        "K212576"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "July 27, 2023",
    "Summary Letter Received Date": "April 28, 2023",
    "Submission Date": "April 26, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed Quality Control Material For Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus",
        "Staphylococcus epidermidis",
        "Staphylococcus lugdunensis",
        "Streptococcus agalactiae",
        "Streptococcus pneumoniae",
        "Streptococcus pyogenes",
        "Enterococcus faecalis",
        "Enterococcus faecium",
        "Streptococcus anginosus group",
        "Staphylococcus spp.",
        "Streptococcus spp.",
        "Listeria spp.",
        "mecA",
        "vanA",
        "vanB"
    ],
    "Specimen Type(s)": [
        "Blood culture sample",
        "Simulated clinical blood culture sample"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Luminex VERIGENE systems"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification test (NAT)",
        "DNA hybridization detection"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Nucleic acid isolation",
        "DNA hybridization assay"
    ],
    "Submission Type(s)": [
        "Control",
        "Kit",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Streck MDx-Chex for BC-GP quality control kit for monitoring Gram-positive bacteria and antimicrobial resistance genes detection with Luminex VERIGENE BC-GP panel",
    "Indications for Use Summary": "Intended for use as an external positive and negative assayed control to monitor the performance of qualitative detection of Gram-positive bacteria and associated antimicrobial resistance genes by the Luminex VERIGENE Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on Luminex VERIGENE systems",
    "fda_folder": "Microbiology"
}